1. Home
  2. COCP vs ARBB Comparison

COCP vs ARBB Comparison

Compare COCP & ARBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COCP
  • ARBB
  • Stock Information
  • Founded
  • COCP 2006
  • ARBB 1997
  • Country
  • COCP United States
  • ARBB Singapore
  • Employees
  • COCP N/A
  • ARBB N/A
  • Industry
  • COCP Biotechnology: Pharmaceutical Preparations
  • ARBB EDP Services
  • Sector
  • COCP Health Care
  • ARBB Technology
  • Exchange
  • COCP Nasdaq
  • ARBB Nasdaq
  • Market Cap
  • COCP 15.3M
  • ARBB 18.0M
  • IPO Year
  • COCP N/A
  • ARBB 2023
  • Fundamental
  • Price
  • COCP $1.52
  • ARBB $0.69
  • Analyst Decision
  • COCP Strong Buy
  • ARBB
  • Analyst Count
  • COCP 1
  • ARBB 0
  • Target Price
  • COCP $7.00
  • ARBB N/A
  • AVG Volume (30 Days)
  • COCP 12.6K
  • ARBB 4.6M
  • Earning Date
  • COCP 05-20-2025
  • ARBB 05-16-2025
  • Dividend Yield
  • COCP N/A
  • ARBB N/A
  • EPS Growth
  • COCP N/A
  • ARBB N/A
  • EPS
  • COCP N/A
  • ARBB N/A
  • Revenue
  • COCP N/A
  • ARBB $24,425,491.00
  • Revenue This Year
  • COCP N/A
  • ARBB N/A
  • Revenue Next Year
  • COCP N/A
  • ARBB N/A
  • P/E Ratio
  • COCP N/A
  • ARBB N/A
  • Revenue Growth
  • COCP N/A
  • ARBB N/A
  • 52 Week Low
  • COCP $1.12
  • ARBB $0.22
  • 52 Week High
  • COCP $3.26
  • ARBB $1.24
  • Technical
  • Relative Strength Index (RSI)
  • COCP 51.20
  • ARBB 49.32
  • Support Level
  • COCP $1.36
  • ARBB $0.65
  • Resistance Level
  • COCP $1.74
  • ARBB $0.73
  • Average True Range (ATR)
  • COCP 0.18
  • ARBB 0.05
  • MACD
  • COCP 0.01
  • ARBB -0.00
  • Stochastic Oscillator
  • COCP 50.00
  • ARBB 27.38

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

About ARBB ARB IOT Group Limited

ARB IOT Group Ltd is engaged in provision of hardware and software of Internet of Things Solutions to meet customers' demand in four business lines, which are IoT Smart Home and Buildings, IoT Smart Agriculture, IoT System Development, and IoT Gadget Distribution. The company delivers holistic solutions with full turnkey deployment from designing, installation, testing, pre-commissioning, and commissioning of various IoT systems and devices as well as integration of automated systems, including installation of wire and wireless and mechatronic works. The company has two operating segments: Internet of Things ('IoT'), Investment holding and others. It earns its maximum profit from the Internet of Things (IoT) segment.

Share on Social Networks: